Cancer Epidemiology Biomarkers & Prevention, Vol 5, Issue 6 441-447, Copyright © 1996 by American Association for Cancer Research

ARTICLES

Tissue antioxidants and postmenopausal breast cancer: the European Community Multicentre Study on Antioxidants, Myocardial Infarction, and Cancer of the Breast (EURAMIC)

P van 't Veer, JJ Strain, J Fernandez-Crehuet, BC Martin, M Thamm, AF Kardinaal, L Kohlmeier, JK Huttunen, JM Martin-Moreno and FJ Kok
Netherlands Organization for Applied Scientific Research (TNO) Food and Nutrition Research Institute, Zeist, The Netherlands.

Antioxidants may protect against free radical mediated carcinogenesis. Epidemiological studies have not confirmed this hypothesis for breast cancer, possibly because of methodological limitations. Time-integrated exposure of alpha-tocopherol and beta-carotene in adipose tissue, and selenium in toenails was investigated in a case-control study among postmenopausal women, ages 50-74 years, from five European countries. The study group comprised 347 incident breast cancer cases and 374 controls. Mean antioxidant levels, adjusted for age and center, did not significantly differ for alpha-tocopherol (cases were 4.5% higher than controls), beta-carotene (3.0% lower), or selenium (1.8% lower). Odds ratios for highest versus lowest tertiles of exposure, adjusted for potential confounders, were 1.15 (95% confidence interval, 0.75-1.77), 0.74 (0.45-1.23), and 0.96 (0.63-1.47), respectively, without evidence for a decreasing trend. No statistically significant interactions were observed. Moreover, a provisional antioxidant score, indicating whether concentrations were above the median for zero, one, two, or all three antioxidants, yielded odds ratios of 1.00 (reference; all below median), 1.58, 1.58, and 1.21, respectively (chi2 for association = 4.00; P = 0.26). These results do not support the hypothesis that antioxidants are important determinants of this hormone-related malignancy among postmenopausal women.

This article has been cited by other articles:

				Y. Cui, J. M Shikany, S. Liu, Y. Shagufta, and T. E Rohan Selected antioxidants and risk of hormone receptor-defined invasive breast cancers among postmenopausal women in the Women's Health Initiative Observational Study Am. J. Clinical Nutrition, April 1, 2008; 87(4): 1009 - 1018. [Abstract] [Full Text] [PDF]

				Y. Cui, S. Vogt, N. Olson, A. G. Glass, and T. E. Rohan Levels of Zinc, Selenium, Calcium, and Iron in Benign Breast Tissue and Risk of Subsequent Breast Cancer Cancer Epidemiol. Biomarkers Prev., August 1, 2007; 16(8): 1682 - 1685. [Abstract] [Full Text] [PDF]

				A. J. Duffield-Lillico, M. E. Reid, B. W. Turnbull, G. F. Combs Jr., E. H. Slate, L. A. Fischbach, J. R. Marshall, and L. C. Clark Baseline Characteristics and the Effect of Selenium Supplementation on Cancer Incidence in a Randomized Clinical Trial: A Summary Report of the Nutritional Prevention of Cancer Trial Cancer Epidemiol. Biomarkers Prev., July 1, 2002; 11(7): 630 - 639. [Abstract] [Full Text] [PDF]

				P. Toniolo, A. L. Van Kappel, A. Akhmedkhanov, P. Ferrari, I. Kato, R. E. Shore, and E. Riboli Serum Carotenoids and Breast Cancer Am. J. Epidemiol., June 15, 2001; 153(12): 1142 - 1147. [Abstract] [Full Text] [PDF]

				T. E. Rohan Invited Commentary: Serum Carotenoids and Breast Cancer Am. J. Epidemiol., June 15, 2001; 153(12): 1148 - 1150. [Full Text] [PDF]

				R. J. Jandacek The Canary in the Cell: A Sentinel Role for {beta}-Carotene J. Nutr., March 1, 2000; 130(3): 648 - 651. [Full Text]